Preventing vascular effects on brain injury and cognition late in life: knowns and unknowns

Owen Carmichael

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

For some researchers, the relationship between prevalent cardiovascular risk factors and late-life cognitive decline is not worthy of further study. It is already known that effective treatment of vascular risk factors lowers risk of such major outcomes as stroke and heart attack, the argument goes; thus, any new information about the relationship between vascular risk factors and another major outcome--late-life cognitive decline--is unlikely to have an impact on clinical practice. The purpose of this review is to probe the logic of this argument by focusing on what is known, and what is not known, about the relationship between vascular risk factors and late-life cognitive decline. The unknowns are substantial: in particular, there is relatively little evidence that current vascular risk factor treatment protocols are adequate to prevent late-life cognitive decline or the clinically silent brain injury that precedes it. In addition, there is relatively little understanding of which factors lead to differential vulnerability or resilience to the effects of vascular risk factors on silent brain injury. Differential effects of different classes of treatments are similarly unclear. Finally, there is limited understanding of the impact of clinically-silent neurodegenerative disease processes on cerebrovascular processes. Further study of the relationships among vascular risk factors, brain injury, and late-life cognitive decline could have a major impact on development of new vascular therapies and on clinical management of vascular risk factors, and there are promising avenues for future research in this direction.

Original languageEnglish (US)
Pages (from-to)371-387
Number of pages17
JournalNeuropsychology Review
Volume24
Issue number3
DOIs
StatePublished - Sep 1 2014
Externally publishedYes

Fingerprint

Brain Injuries
Cognition
Blood Vessels
Clinical Protocols
vascular factor
Neurodegenerative Diseases
Therapeutics
Stroke
Myocardial Infarction
Research Personnel
Cognitive Dysfunction

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Preventing vascular effects on brain injury and cognition late in life : knowns and unknowns. / Carmichael, Owen.

In: Neuropsychology Review, Vol. 24, No. 3, 01.09.2014, p. 371-387.

Research output: Contribution to journalArticle

@article{ee52b139019b4171b4adb3fa19476f8e,
title = "Preventing vascular effects on brain injury and cognition late in life: knowns and unknowns",
abstract = "For some researchers, the relationship between prevalent cardiovascular risk factors and late-life cognitive decline is not worthy of further study. It is already known that effective treatment of vascular risk factors lowers risk of such major outcomes as stroke and heart attack, the argument goes; thus, any new information about the relationship between vascular risk factors and another major outcome--late-life cognitive decline--is unlikely to have an impact on clinical practice. The purpose of this review is to probe the logic of this argument by focusing on what is known, and what is not known, about the relationship between vascular risk factors and late-life cognitive decline. The unknowns are substantial: in particular, there is relatively little evidence that current vascular risk factor treatment protocols are adequate to prevent late-life cognitive decline or the clinically silent brain injury that precedes it. In addition, there is relatively little understanding of which factors lead to differential vulnerability or resilience to the effects of vascular risk factors on silent brain injury. Differential effects of different classes of treatments are similarly unclear. Finally, there is limited understanding of the impact of clinically-silent neurodegenerative disease processes on cerebrovascular processes. Further study of the relationships among vascular risk factors, brain injury, and late-life cognitive decline could have a major impact on development of new vascular therapies and on clinical management of vascular risk factors, and there are promising avenues for future research in this direction.",
author = "Owen Carmichael",
year = "2014",
month = "9",
day = "1",
doi = "10.1007/s11065-014-9264-7",
language = "English (US)",
volume = "24",
pages = "371--387",
journal = "Neuropsychology Review",
issn = "1040-7308",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Preventing vascular effects on brain injury and cognition late in life

T2 - knowns and unknowns

AU - Carmichael, Owen

PY - 2014/9/1

Y1 - 2014/9/1

N2 - For some researchers, the relationship between prevalent cardiovascular risk factors and late-life cognitive decline is not worthy of further study. It is already known that effective treatment of vascular risk factors lowers risk of such major outcomes as stroke and heart attack, the argument goes; thus, any new information about the relationship between vascular risk factors and another major outcome--late-life cognitive decline--is unlikely to have an impact on clinical practice. The purpose of this review is to probe the logic of this argument by focusing on what is known, and what is not known, about the relationship between vascular risk factors and late-life cognitive decline. The unknowns are substantial: in particular, there is relatively little evidence that current vascular risk factor treatment protocols are adequate to prevent late-life cognitive decline or the clinically silent brain injury that precedes it. In addition, there is relatively little understanding of which factors lead to differential vulnerability or resilience to the effects of vascular risk factors on silent brain injury. Differential effects of different classes of treatments are similarly unclear. Finally, there is limited understanding of the impact of clinically-silent neurodegenerative disease processes on cerebrovascular processes. Further study of the relationships among vascular risk factors, brain injury, and late-life cognitive decline could have a major impact on development of new vascular therapies and on clinical management of vascular risk factors, and there are promising avenues for future research in this direction.

AB - For some researchers, the relationship between prevalent cardiovascular risk factors and late-life cognitive decline is not worthy of further study. It is already known that effective treatment of vascular risk factors lowers risk of such major outcomes as stroke and heart attack, the argument goes; thus, any new information about the relationship between vascular risk factors and another major outcome--late-life cognitive decline--is unlikely to have an impact on clinical practice. The purpose of this review is to probe the logic of this argument by focusing on what is known, and what is not known, about the relationship between vascular risk factors and late-life cognitive decline. The unknowns are substantial: in particular, there is relatively little evidence that current vascular risk factor treatment protocols are adequate to prevent late-life cognitive decline or the clinically silent brain injury that precedes it. In addition, there is relatively little understanding of which factors lead to differential vulnerability or resilience to the effects of vascular risk factors on silent brain injury. Differential effects of different classes of treatments are similarly unclear. Finally, there is limited understanding of the impact of clinically-silent neurodegenerative disease processes on cerebrovascular processes. Further study of the relationships among vascular risk factors, brain injury, and late-life cognitive decline could have a major impact on development of new vascular therapies and on clinical management of vascular risk factors, and there are promising avenues for future research in this direction.

UR - http://www.scopus.com/inward/record.url?scp=84929042885&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929042885&partnerID=8YFLogxK

U2 - 10.1007/s11065-014-9264-7

DO - 10.1007/s11065-014-9264-7

M3 - Article

C2 - 25085314

AN - SCOPUS:84929042885

VL - 24

SP - 371

EP - 387

JO - Neuropsychology Review

JF - Neuropsychology Review

SN - 1040-7308

IS - 3

ER -